Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Satoshi Ide

Showing results (31-40 of 44) with videos related to

Pageof 5
Sort By:
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 29, 2020
Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workersTetsuya Suzuki, Kayoko Hayakawa, Akira Ainai, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 10, 2021
Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in JapanTetsuya Suzuki, Yusuke Asai, Satoshi Ide, et al.
Infection Prevention in Practice|July 28, 2021
Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severityKeiji Nakamura, Shinichiro Morioka, Satoshi Kutsuna, et al.
Gene|September 17, 2020
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19Masaya Sugiyama, Noriko Kinoshita, Satoshi Ide, et al.
Global Health & Medicine|December 17, 2020
COVID-19 can suddenly become severe: a case series from Tokyo, JapanKeiji Nakamura, Satoshi Ide, Sho Saito, et al.
Psychiatry Research|May 11, 2020
Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospitalShinichiro Morioka, Sho Saito, Kayoko Hayakawa, et al.
Idcases|November 22, 2021
Extracorporeal membrane oxygenation may decrease the plasma concentration of remdesivir in a patient with severe coronavirus disease 2019Satoshi Ide, Sho Saito, Tsubasa Akazawa, et al.
Internal Medicine (Tokyo, Japan)|November 2, 2020
Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, JapanYutaro Akiyama, Shinichiro Morioka, Yuji Wakimoto, et al.
Journal of Clinical Apheresis|December 16, 2020
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19Daisuke Katagiri, Masahiro Ishikane, Yusuke Asai, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 10, 2021
Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus diseaseAyako Okuhama, Masatoshi Hotta, Masahiro Ishikane, et al.
Pageof 5

Showing results (31-40 of 44) with videos related to

Sort By:
Pageof 5
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|September 29, 2020
Effectiveness of personal protective equipment in preventing severe acute respiratory syndrome coronavirus 2 infection among healthcare workersTetsuya Suzuki, Kayoko Hayakawa, Akira Ainai, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 10, 2021
Factors associated with high antibody titer following coronavirus disease among 581 convalescent plasma donors: A single-center cross-sectional study in JapanTetsuya Suzuki, Yusuke Asai, Satoshi Ide, et al.
Infection Prevention in Practice|July 28, 2021
Environmental surface and air contamination in severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) patient rooms by disease severityKeiji Nakamura, Shinichiro Morioka, Satoshi Kutsuna, et al.
Gene|September 17, 2020
Serum CCL17 level becomes a predictive marker to distinguish between mild/moderate and severe/critical disease in patients with COVID-19Masaya Sugiyama, Noriko Kinoshita, Satoshi Ide, et al.
Global Health & Medicine|December 17, 2020
COVID-19 can suddenly become severe: a case series from Tokyo, JapanKeiji Nakamura, Satoshi Ide, Sho Saito, et al.
Psychiatry Research|May 11, 2020
Psychiatric burdens or stress during hospitalization and concerns after discharge in patients with severe acute respiratory syndrome coronavirus-2 isolated in a tertiary care hospitalShinichiro Morioka, Sho Saito, Kayoko Hayakawa, et al.
Idcases|November 22, 2021
Extracorporeal membrane oxygenation may decrease the plasma concentration of remdesivir in a patient with severe coronavirus disease 2019Satoshi Ide, Sho Saito, Tsubasa Akazawa, et al.
Internal Medicine (Tokyo, Japan)|November 2, 2020
Non-COVID-19 Patients with Life-threatening Diseases Who Visited a Fever Clinic: A Single-center, Observational Study in Tokyo, JapanYutaro Akiyama, Shinichiro Morioka, Yuji Wakimoto, et al.
Journal of Clinical Apheresis|December 16, 2020
Direct hemoperfusion using a polymyxin B-immobilized polystyrene column for COVID-19Daisuke Katagiri, Masahiro Ishikane, Yusuke Asai, et al.
Journal of Infection and Chemotherapy : Official Journal of the Japan Society of Chemotherapy|November 10, 2021
Fatty liver on computed tomography scan on admission is a risk factor for severe coronavirus diseaseAyako Okuhama, Masatoshi Hotta, Masahiro Ishikane, et al.
Pageof 5